Position in JNJ
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$3,296,154,468
+$242,987,649 QoQ
Shares Held
12,978,519
+3.9% QoQ
Ownership
0.539%
of shares outstanding
% of Portfolio
0.81%
of 13F equity value
Holder Rank
#30
of 4,676 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Nuveen, LLC holds $17,178,530,722 across 15 Drug Manufacturers - General names. JNJ ranks #2 (19.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
5,061,510 | $6,070,927,443 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
12,978,519 | $3,296,154,468 | |
| 3 | ABBV |
AbbVie Inc.
|
9,509,991 | $2,393,094,134 | |
| 4 | AZN |
Astrazeneca PLC
|
7,183,115 | $1,362,062,264 | |
| 5 | MRK |
Merck & Co., Inc.
|
9,662,399 | $1,241,618,271 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
8,336,930 | $1,053,287,734 | |
| 7 | AMGN |
Amgen Inc
|
2,345,865 | $849,484,633 | |
| 8 | PFE |
Pfizer Inc
|
14,445,787 | $347,854,549 |
All Filings in JNJ
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,296,154,468 | 12,978,519 | Shares | Defined | 2026-08-11 | |
| 2026-03-31 | $3,053,166,819 | 12,490,455 | Shares | Defined | 2026-04-30 | |
| 2025-12-31 | $2,195,567,937 | 10,609,171 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $1,840,331,324 | 9,925,204 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $1,372,686,805 | 8,986,493 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $1,369,188,140 | 8,256,079 | Shares | Defined | 2025-05-12 | |
| No filing history on record for this holder in this stock. | ||||||